medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2003, Number 1

<< Back Next >>

Rev Med UV 2003; 3 (1)

Estudio exploratorio de las lesiones premalignas en el reporte citológico del cuello uterino

Coronel-Brizio P, Coronel PP

Language: Spanish
References: 20
Page: 23-30
PDF size: 81.85 Kb.


ABSTRACT

Introduction. Premalign lesions (PL) on the cervical uterine have aroused great interest since the beginning of the past century. Cullen was the first author to describe neoplasic cells limited to the cervix epithelium, later followed by Rubin.
Objetive. To find the frequency and concomitant factors of PL of the cervical uterine by means of the exploratory research of the cytological report of the program of cervical cancer (CC).
Method. A retrospective study of 55,424 cervical cytologies and the frequency of PL in the Pathological Anatomy Services at the State Cancerology Center (Centro Estatal de Cancerología (CECAN) ), Health Services of Veracruz in Xalapa, Veracruz.
Results. In the cytological diagnosis, the inflammatory process was predominant in 85.73%, followed by 3.43% of PL and .08% of invaders. In 2.23% diagnosis was not possible due to inadequate sampling. Most of PL corresponds to the Sanitary Jurisdictions of Pánuco, Tuxpam, San Andrés Tuxtla and Xalapa.
Conclusions. The frequency of PL and CC of the evaluated SJ is inferior to the national mean. An inflammatory reaction occurred in more than 85% of the total of cytologies evaluated. A careful macroscopic evaluation of the cervix leads us to a diagnostic impression of the existence of invading cancer and infection in the inferior genital tracto. The Risk Factors found were: HPV infections, cervico-vaginal infections and use of hormonals. Age group 45 – 64 was the most vulnerable in the cases of PL and CC.


REFERENCES

  1. Cullen TS. Cancer of the uterus. New York: Appleton and Co, 1900.

  2. Rubin JC. The pathological diagnosis of incipient carcinoma of the uterus. Am J Obstet 1910; 62:668.

  3. Copeland JL. Ginecología. 2ª edición. Argentina: Editorial Médica Panamericana, 2000: 1321.

  4. Gonzalez-Merlo J. Oncología ginecológica. 2ª edición. España: Masson, 2000 : 121.

  5. Weid GL. Procedings of the first international congress on exfoliative cytology. Philadelphia: Lippincott, 1961: 283-286.

  6. DiSaia JP. Creasman TW. Oncología ginecológica clínica. 5a edición. España: Artcourt Brace, 1998: 428.

  7. National Center Institute. The 1988 Bethesda System for reporting cervical-vaginal cytological diagnoses. JAMA 1989; 262-931.

  8. Berek SJ. Neville HF. Gynecologic oncology. 3a edición. Philadelphia, USA: Lippincott Williams and Wilkins. 2000: 271.

  9. Modificación de la Norma Oficial Mexicana NOM-014-SSA2-1994, para la prevención, detección, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer del cuello uterino.

  10. Ahued-Ahued R. Fernández del Castillo SC. Ginecología y obstetricia aplicadas. 1ª edición. México, D.F.: JGH Editores S.A. de C.V., 2000: 341.

  11. Aguilera-Delgadillo M. “Factores de riesgo para el cáncer cervical en las mujeres de Zacatecas, México”. Salud Pública Mex 1988; 40: 330-338.

  12. Lazcano-Ponce EC. Rojas-Martínez R. López-Acuña M. López Carrillo L. Hernández-Avila M. “Factores de riesgo reproductivo y cáncer cervico-uterino en la ciudad de México”. Salud Pública Mex 1993; 5(1): 43-51.

  13. Hoskins JW. Perez AC. Young CR. Gynecologic oncology. 3a edición. Philadelphia, USA.: Lippincott Williams and Wilkins, 2000: 735.

  14. Secretaria de Salud. Programa de acción: Cáncer cérvico-uterino. 1ª edición. México, D.F.: Secretaria de Salud, 2002: 17.

  15. Mishell RD. Stenchever AM. Herbst LA. Tratado de ginecología. 3a edición. Madrid, España: Harcourt Brace, 1999: 801.

  16. Piper J. “Oral contraceptives and cervical cancer”. Gynecol Oncol 1985; 22:1-15.

  17. Scheider A. Holz M. Gissmann L. “Prevalence of genital HPV infections in pregnant women”. Int Cancer 1987; 40:198206.

  18. Shingleton HM. Fowler WC. Jordan JA. Laurence WD. Oncología Ginecológica.1a edición. México. D.F.: Mc Graw Hill, 1998:42.

  19. Dexeus-Trias de Bes S. Grases GP. Sinopsis de oncología ginecológica. 1ª edición. Madrid. España: Masson S.A., 1996: 59.

  20. Morimura Y, Fujimori K, Soeda S, Hashimoto T, Takano Y, Yamada H, Yanagida K, Sato A. “Cervical cytology during pregnancy comparison with nonpregnant women and management of pregnant women with abnormal cytology”. Fukushima J Med Sci 2002 Jun;48(1):27-37 (resumen).




2020     |     www.medigraphic.com